Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI-Powered MRI could slash heart scan time

NCT ID NCT07061821

First seen Feb 01, 2026 · Last updated Jun 19, 2026 · Updated 21 times

Summary

This study tests whether a new, faster cardiac MRI that uses artificial intelligence can accurately measure heart function in people with left ventricular hypertrophy (thickened heart muscle). The standard MRI requires multiple breath-holds, which can be hard for elderly or breathless patients. The new method aims to shorten scan time while maintaining image quality. Researchers will compare the two methods in 61 adults referred for a heart MRI.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP-LEARNING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHRU Amiens

    RECRUITING

    Amiens, 80480, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

accelerated cardiac cine-MRI sequence with deep learning-based image reconstruction

What this could lead to

If successful, this could make heart MRI scans faster and more comfortable for patients, while still providing accurate measurements of heart function.

What could go wrong

This is a small, early-stage study (61 participants) comparing two imaging methods, not testing a treatment. The new method may not match the standard's accuracy in all cases.

Conditions

The condition(s) this trial relates to.

Hypertrophy, Left Ventricular

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.